•
Dec 31, 2024

Cardlytics Q4 2024 Earnings Report

Expected Revenue:$63.6M
-28.9% YoY
Expected EPS:-$0.2
266.7% YoY

Key Takeaways

Cardlytics' Q4 2024 revenue was $74.0 million, a 17.0% decline year-over-year, mainly due to lower advertising demand. The company reported a net loss of $15.6 million but improved adjusted EBITDA to $6.4 million. MAUs decreased slightly, while ARPU dropped 16.7% year-over-year.

Total revenue for Q4 2024 was $74.0 million, down 17.0% year-over-year.

Net loss was $15.6 million, significantly lower than the $100.8 million loss in Q4 2023.

Adjusted EBITDA was $6.4 million, compared to $10.0 million in Q4 2023.

MAUs decreased by 0.4% to 167.3 million, while ARPU declined by 16.7%.

Total Revenue
$74M
Previous year: $89.2M
-17.0%
EPS
$0
Previous year: $0.14
-100.0%
Monthly Active Users
167.3M
Previous year: 168M
-0.4%
Average Revenue per User
$0.44
Previous year: $0.53
-17.0%
Gross Profit
$32.7M
Previous year: $40.6M
-19.4%
Cash and Equivalents
$65.6M
Previous year: $91.8M
-28.6%
Free Cash Flow
-$1.46M
Previous year: -$763K
+91.2%
Total Assets
$393M
Previous year: $574M
-31.6%

Cardlytics

Cardlytics

Forward Guidance

Cardlytics expects a challenging Q1 2025 with lower revenue and billings but aims to improve profitability.

Positive Outlook

  • Cost management efforts expected to further reduce losses in 2025.
  • Investment in platform modernization to drive future growth.
  • Expansion of partnerships and advertisers to improve revenue streams.
  • Sequential improvements expected in Adjusted EBITDA throughout 2025.
  • Company remains focused on achieving positive Adjusted EBITDA for the year.

Challenges Ahead

  • Revenue expected to decline 16%-11% in Q1 2025.
  • Billings projected to drop between 13%-10% in Q1 2025.
  • Adjusted Contribution expected to decline between 19%-14%.
  • Adjusted EBITDA for Q1 2025 projected to be negative, ranging from -$7.5M to -$4.0M.
  • Macroeconomic conditions may impact advertiser spending.